Sinew Pharma Inc. (TPEX:6634)
Taiwan · Delayed Price · Currency is TWD 67.00
+0.10 (0.15%)
May 29, 2026, 1:51 PM CST
Sinew Pharma Market Cap
Sinew Pharma has a market cap or net worth of 4.78 billion as of May 29, 2026. Its market cap has increased by 51.53% in one year.
Market Cap
4.78B
Enterprise Value
3.74B
Revenue
47.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
67.00
Market Cap Chart
Since June 29, 2017, Sinew Pharma's market cap has increased from 1.90B to 4.78B, an increase of 151.27%. That is a compound annual growth rate of 10.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 4.78B | 71.07% |
| Dec 31, 2025 | 2.79B | -17.68% |
| Dec 31, 2024 | 3.39B | -29.30% |
| Dec 29, 2023 | 4.80B | -34.51% |
| Dec 30, 2022 | 7.33B | 29.47% |
| Dec 30, 2021 | 5.66B | 19.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sinphar Pharmaceutical | 5.84B |
| Mycenax Biotech | 5.63B |
| AnnJi Pharmaceutical | 5.52B |
| ACRO Biomedical | 5.31B |
| Panion & Bf Biotech | 5.17B |
| UnicoCell Biomed | 5.08B |
| Pharmosa Biopharm | 4.69B |
| Steminent Biotherapeutics | 4.61B |